维普中文期刊产品整合服务
78篇 您的检索式:作者名="Jeng W Y"
    题名 作者 年代 出处 被引量
1Angiotensinogen gene polymorphism is associated with insulin resistance in nondiabetic men with or without coronary heart disease显示文摘SHEU W H LEE W J JENG C Y 1998Am Heart J1998,136,:1
2A Novel 5DOF Thin Coplanar Nanometer--scale Stage 显示文摘Jywe W Y Jeng Y R Liu C H 2008Precision Engineering2008,32,:1
3The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors显示文摘Skiles J W Gonnella N C Jeng A Y 2004Curr Med Chem2004,11,22:1
4Spread of hepatitis E virus among different-aged pigs: two year survey in Taiwan显示文摘Wu J C Chen C M Chiang T Y Tsai W H Jeng W J Sheen I J Lin C C Meng X J 2002J Med Virol2002,66,4:1
5The Design, Structure, and Clinical Update of Small Molecular Weight Matrix Metatloproteinase Inlfibitons显示文摘Skiles J W Gonnella N C Jeng A Y 2004Current Medicinal Chemistry2004,11,:1
6Mutations in the substrate entrance region of β- glucosidase from Trichoderma reesei improve enzyme activity and thermostability显示文摘Lee H L Chang C K Jeng W Y 2012Protein Engineering Design and Selection2012,25,11:1
7Synthetic peroxisome proliferator - activated receptor agonist, rosiglitazone, increases plasma levels of adi- ponectin in type Ⅱ diabetic patients 显示文摘Yang W S Jeng C Y Wu T J 2002Diabetes Care2002,25,2:1
8Fast codeword search algorithm using wavelet transform and partial distance search techniques 显示文摘Hwang W J Jeng S S Chen B Y 1997Electronics Letter1997,33,5:1
9Crystal structure of IcaR, a repressor of the TetR family implicated in biofilm formation in Staphylococcus epidermidis 显示文摘Jeng W Y Ko T P Liu C I 2008Nucleic Acids Res2008,36,5:1
10Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species显示文摘Wells PG Bhuller Y Chen CS Jeng W Kasapinovic S Kennedy JC 2005Toxicol Appl Pharmacol2005,207,2:1
11Data-based system modeling using a type-2 fuzzy neural network with a hybrid learning algorithm 显示文摘YEH C Y JENG W R LEE S J 2011IEEE Transactions on Neural Networks2011,22,12:1
12Study of an assembly tolerance allocation model based on Monte Carlo simulation显示文摘LIN C Y HUANG W H JENG M C 1997Materials Processing Technology1997,70,13:1
13Tribological analysis of CMP with partial asperity contact显示文摘JENG Y R HUANG P Y PAN W C 2003Journal of the Elec-trochemical Society2003,150,10:1
14Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase Ⅱ randomised placebo-controlled double-blind multicentre trial显示文摘Rationale Haematoma growth is common early after intracerebral haemorrhage(ICH),and is a key determinant of outcome.Tranexamic acid,a widely available antifibrinolytic agent with an excellent safety profile,may reduce haematoma growth.Methods and design Stopping intracerebral haemorrhage with tranexamic acid for hyperacute onset presentation including mobile stroke units(STOP-MSU)is a phase Ⅱ double-blind,randomised,placebo-controlled,multicentre,international investigator-led clinical trial,conducted within the estimand statistical framework.Hypothesis In patients with spontaneous ICH,treatment with tranexamic acid within 2 hours of onset will reduce haematoma expansion compared with placebo.Sample size estimates A sample size of 180 patients(90 in each arm)would be required to detect an absolute difference in the primary outcome of 20%(placebo 39%vs treatment 19%)under a two-tailed significance level of 0.05.An adaptive sample size re-estimation based on the outcomes of 144 patients will allow a possible increase to a prespecified maximum of 326 patients.Intervention Participants will receive 1 g intravenous tranexamic acid over 10 min,followed by 1 g intravenous tranexamic acid over 8 hours;or matching placebo.Primary efficacy measure The primary efficacy measure is the proportion of patients with haematoma growth by 24±6 hours,defined as either≥33%relative increase or≥6 mL absolute increase in haematoma volume between baseline and follow-up CT scan.Discussion We describe the rationale and protocol of STOP-MSU,a phase Ⅱ trial of tranexamic acid in patients with ICH within 2 hours from onset,based in participating mobile stroke units and emergency departments.Nawaf Yassi Henry Zhao Leonid Churilov Bruce C V Campbell Teddy Wu Henry Ma Andrew Cheung Timothy Kleinig Helen Brown Philip Choi Jiann-Shing Jeng Annemarei Ranta Hao-Kuang Wang Geoffrey C Cloud Rohan Grimley Darshan Shah Neil Spratt Der-Yang Cho Karim Mahawish Lauren Sanders John Worthington Ben Clissold Atte Meretoja Vignan Yogendrakumar Mai Duy Ton Duc Phuc Dang Nguyen Thai My Phuong Huy-Thang Nguyen Chung Y Hsu Gagan Sharma Peter J Mitchell Bernard Yan Mark W Parsons Christopher Levi Geoffrey A Donnan Stephen M Davis 2022Stroke & Vascular Neurology2022,7,2:1
15Design and Control of a Long- traveling Nano- positioning Stage显示文摘Liu C Jywe W Y Jeng Y R 2010Precision Engineering2010,34,3:1
16p53 gene and Wnt signaling in benign neoplasms: beta - catenin mutations in hepatic adenoma but not in focal nodular hyperplasia 显示文摘CHEN Y W JENG Y M YEH S H 2002Hepatology2002,36,1:1
17Supplementation with vitamins C and E enhances cytokine production by peripheral blood mononuclear cells in healthy adults显示文摘Jeng K C Yang C S Siu W Y 1996Am J Clin Nutr1996,64,6:1
18Updating generalized association rules with evolving taxonomies 显示文摘Tseng M C Lin W Y Jeng R 2008Applied Intelligence2008,29,3:1
19Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease显示文摘Huang Y W Jeng J S Tsai C F 2007Mov Disord2007,22,4:1
20Supplementation with Vitamin C and E enhances cytokine production by peripher- al blood mononuclear cells in healthy adults显示文摘Jeng K C Yang C S Siu W Y 1996Am J Clin Nutr1996,64,6:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费